Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
158
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of Steroid Therapy on Pneumonic Chronic Obstructive Pulmonary Disease Exacerbation: A Multicenter, Retrospective Cohort Study

Akihiro Shiroshita1 Department of Respiratory Medicine, Ichinomiyanishi Hospital, Ichinomiya, Japan;2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0262-459X
ORCID Icon,
Hiroshi Shiba3 Post Graduate Education Center, Kameda Medical Center, Kamogawa, Japan
,
Yu Tanaka4 Department of Pulmonology, Kameda Medical Center, Kamogawa, Japan
,
Akihiro Nishi5 General Medicine, Awa Regional Medical Center, Tateyama, Japan
,
Kenya Sato6 Department of Thoracic Medicine, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan
,
Chigusa Shirakawa7 Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan
&
Yuki Kataoka7 Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan;8 Hospital Care Research Unit, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JapanORCID Iconhttps://orcid.org/0000-0001-7982-5213
ORCID Icon show all
Pages 2539-2547 | Published online: 19 Oct 2020

References

  • World Health Organization. The top 10 causes of death; 2018 Available from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 213, 2020.
  • SøgaardM, MadsenM, LøkkeA, HilbergO, SørensenHT, ThomsenRW. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chron Obstruct Pulmon Dis. 2016;11:455–465. doi:10.2147/COPD.S9617927042038
  • YangIA, ClarkeMS, SimEHA, FongKM. Inhaled corticosteroid for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;(7):CD002991.22786484
  • WaltersJA, TanDJ, WhiteCJ, GibsonPG, Wood-BakerR, WaltersEH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(9):CD001288.25178099
  • SternA, SkalskyK, AvniT, CarraraE, LeiboviciL, PaulM. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017;(12):CD007720.29236286
  • SchollT, KiserTH, VondracekSF. Evaluation of systemic corticosteroids in patients with an acute exacerbation of COPD and a diagnosis of pneumonia. Chronic Obstr Pulm Dis. 2018;5(1):57–65.29629405
  • AnthonisenNR, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
  • ShindoY, ItoR, KobayashiD, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188(8):985–995. doi:10.1164/rccm.201301-0079OC23855620
  • TorresA, SibilaO, FerrerM, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677–686. doi:10.1001/jama.2015.8825688779
  • ChalmersJD, SinganayagamA, AkramAR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax. 2010;65(10):878–883. doi:10.1136/thx.2009.13328020729231
  • ShorrAF, SunX, JohannesRS, YaitanesA, TabakYP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–1183. doi:10.1378/chest.10-303521527510
  • LauB, ColeSR, GangeSJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244–256. doi:10.1093/aje/kwp10719494242
  • TabakYP, SunX, JohannesRS, GuptaV, ShorrAF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–1602. doi:10.1001/archinternmed.2009.27019786679
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2020 Available from https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed 213, 2020.
  • WedzichaJA, MiravitllesM, HurstJR, et al. Management of COPD exacerbations: a European respiratory society/American thoracic society guideline. Eur Respir J. 2017;49(3):1600791. doi:10.1183/13993003.00791-201628298398
  • HuertaA, CrisafulliE, MenéndezR, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest. 2013;144(4):1134–1142. doi:10.1378/chest.13-048823828375
  • DoeingDC, SolwayJ. Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol. 2013;114(7):834–843. doi:10.1152/japplphysiol.00950.201223305987
  • SaltürkC, KarakurtZ, AdiguzelN, et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis. 2015;10:1837–1846. doi:10.2147/COPD.S8805826392758
  • SchorJD, LevkoffSE, LipsitzLA, et al. Risk factors for delirium in hospitalized elderly. JAMA. 1992;267(6):827–831. doi:10.1001/jama.1992.034800600730331732655
  • QuintanaJM, EstebanC, UnzurrunzagaA, et al. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments. BMC Med. 2014;12(1):66. doi:10.1186/1741-7015-12-6624758312

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.